Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20072
20081
20101
20112
20131
20152
20163
20193
20203
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Achieve Life Sciences1
Amgen1
Basilea Pharmaceutica1
EMD Serono Research & Development Institute, Inc.1
Infinity Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms23
Carcinoma, Transitional Cell8
Neoplasms4
Ovarian Neoplasms4
Breast Neoplasms3
Urethral Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Esophageal Neoplasms2
Lung Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.